Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor IX Deficiency”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Post-approval studies (Phase 4)Study completedNCT00749476
What this trial is testing

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 1
Not applicableStudy completedNCT02568202
What this trial is testing

Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Who this might be right for
HaemostasisCongenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 449
Not applicableStudy completedNCT03430154
What this trial is testing

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Who this might be right for
Haemophilia A, Haemophilia B, Obesity
Novo Nordisk A/S 317
Early research (Phase 1)Study completedNCT03075670
What this trial is testing

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 15
Large-scale testing (Phase 3)Study completedNCT02250573
What this trial is testing

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Who this might be right for
Haemophilia B
Bio Products Laboratory
Not applicableStudy completedNCT01220141
What this trial is testing

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 51
Large-scale testing (Phase 3)Study completedNCT02141074
What this trial is testing

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 54
Not applicableEnrolling By InvitationNCT06831734
What this trial is testing

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Who this might be right for
Haemophilia A, Haemophilia B
Novo Nordisk A/S 30
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Not applicableStudy completedNCT03901755
What this trial is testing

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Swedish Orphan Biovitrum 151
Not applicableStudy completedNCT00853086
What this trial is testing

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 139
Early research (Phase 1)Study completedNCT01555749
What this trial is testing

Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 8
Large-scale testing (Phase 3)Looking for participantsNCT07094087
What this trial is testing

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

Who this might be right for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring 200
Next Page